# Telomere Length and COVID-19 Severity: A Comparative Cross-Sectional Study Across the Clinical Spectrum

**Authors:** Flora Bacopoulou, Anastasios Tentolouris, Eleni Koniari, Dimitrios Kalogirou, Dimitrios Basoulis, Ioanna Eleftheriadou, Pinelopi Grigoropoulou, Vasiliki Efthymiou, Konstantina K. Georgoulia, Ioanna A. Anastasiou, Stavroula Papadodima, George Chrousos, Nikolaos Tentolouris

PMC · DOI: 10.3390/healthcare13202656 · Healthcare · 2025-10-21

## TL;DR

Shorter telomeres are linked to more severe cases of COVID-19, suggesting a possible role in disease progression.

## Contribution

This study identifies a novel association between telomere length and severity of SARS-CoV-2 infection in a cross-sectional design.

## Key findings

- Severe COVID-19 patients had significantly shorter telomeres compared to non-severe patients and controls.
- Telomere length was independently associated with disease severity in logistic regression analysis.
- Females had longer telomeres than males, but no significant age correlation was found.

## Abstract

Background: Telomere attrition has been implicated in immune function and vulnerability to infectious diseases. However, the relation between telomere length and COVID-19 severity remains unclear. Methods: In this cross-sectional study, patients aged 30–75 years, with confirmed SARS-CoV-2 infection, as well as age- and BMI-matched controls without COVID-19, were recruited over a period of 1 year (2021–2022) from the outpatient clinics and wards of the General Hospitals “Laiko” and “Elpis” in Athens, Greece. Telomere length, expressed as a telomere to single-copy gene (T/S) ratio, was measured in all participants using a quantitative PCR-based method. Participants’ clinical, biochemical, demographic, and respiratory parameters were assessed in relation to their telomere length. Results: Study participants included a total of 139 individuals divided into three groups: controls (n = 34), patients with non-severe COVID-19 (n = 50), and patients with severe COVID-19 (n = 55). Patients with severe COVID-19 had significantly shorter telomeres when compared to both the non-severe COVID-19 group and controls (p < 0.001). Logistic regression analysis confirmed that telomere length was independently associated with disease severity (p < 0.001). Females demonstrated longer telomeres than males (p = 0.039), but no significant correlation was found between telomere length and age. When patients with non-severe and severe COVID-19 were analyzed together, no significant difference in telomere length was observed compared to controls (p = 0.727). Conclusions: Shortened telomeres may be linked to more severe forms of COVID-19, suggesting a potential role for telomere biology in disease progression. Results highlight the need for further research into telomere dynamics as a biomarker for disease susceptibility and outcome in viral infections.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382), infectious diseases (MESH:D003141), viral infections (MESH:D014777)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12564613/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12564613/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12564613/full.md

---
Source: https://tomesphere.com/paper/PMC12564613